Global perspective on acute coronary syndrome: a burden on the young and poor

Rajesh Vedanthan1, Benjamin Seligman1, Valentin Fuster2

  • 1From the Department of Medicine, Division of Cardiology, Zena and Michael A. Wiener Cardiovascular Institute and Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai, New York, NY (R.V., V.F.); Department of Biology and School of Medicine, Stanford University, Palo Alto, CA (B.S.); and Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (V.F.).

Insights

Ischemic heart disease (IHD) and acute coronary syndrome (ACS) disproportionately affect low- and middle-income countries (LMICs), often striking at younger ages. Addressing global IHD and ACS requires overcoming implementation challenges in LMICs through policy and coordinated efforts.

Area of Science:

  • Cardiovascular Medicine
  • Global Health
  • Public Health Policy

Background:

  • Ischemic heart disease (IHD) is the leading cause of global mortality and disability.
  • Low- and middle-income countries (LMICs) bear a substantial burden, with younger age-of-death and higher impact on the poor.
  • Acute coronary syndrome (ACS) data in LMICs are growing, filling previous research gaps.

Purpose of the Study:

  • To highlight the significant global burden of IHD and ACS, particularly in LMICs.
  • To identify challenges in implementing preventive and treatment strategies in LMICs.
  • To emphasize the need for intersectoral policies and global coordination for disease control.

Main Methods:

  • Review of existing literature on IHD and ACS in LMICs.
  • Analysis of risk factors, prevention, and treatment strategies.
  • Examination of implementation challenges and policy requirements.

Main Results:

  • IHD and ACS impact LMICs more severely, affecting younger populations and the poor.
  • While prevention and treatment tools exist, their implementation in LMICs faces significant hurdles.
  • Successful health promotion, clinical care, and policy efforts require scaling and global coordination.

Conclusions:

  • Effective control of IHD and ACS globally necessitates addressing implementation gaps in LMICs.
  • Intersectoral policy initiatives and global coordination are critical for reducing the burden of these diseases.
  • Scaling successful interventions is essential to manage the worldwide impact of ACS and IHD.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.0K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
923
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
617